| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| OP Bancorp (OPBK) | Keefe, Bruyette & Woods (A Stifel Company) | $20.00 | N/C | |||
| Tiberius Acquisition (TIBRU) (u) | Cantor/ Dowling & Partners Securities | 15.00 | $10.00 | $10.00 | $150.00 | n.a. |
| Vrio (VRIO) | Goldman Sachs/ J.P. Morgan/ Citigroup/ Morgan Stanley | $100.00 | n.a. | |||
| N/C + No Call – Stock is quoted on the OTC Market Group’s OTCQB Market under the symbol “OPBK” | ||||||
| n.a. (not available) | ||||||
| u (unit offering) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| Univision Holdings (UVN) | Morgan Stanley/ Goldman Sachs/ Deutsche Bank Securities | $350.00 | ||||
| New Terms | ||||||
| Arcus Biosciences (RCUS) | Citigroup/ Goldman Sachs/ Leerink Partners | 7.10 | $13.00 | $15.00 | $99.40 | S/O |
| Bridgewater Bancshares (BWB) | Sandler O’Neill & Partners/ D.A. Davidson | 7.10 | $13.00 | $15.00 | $99.40 | S/O |
| Golden Bull Ltd (DNJR) | ViewTrade Securities | 1.55 | $4.00 | $4.50 | $6.59 | S/O |
| Molino Cañuelas S.A.C.I.F.I.A. (MOLC) | BofA Merrill Lynch/ J.P. Morgan/ UBS Investment Bank | $100.00 | S/O | |||
| Zscaler (ZS) | Morgan Stanley/ Goldman Sachs | 10.00 | $10.00 | $12.00 | $110.00 | S/O |
| S/O (Subscribers Only) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of March 5, 2018 | Manager(s) | Offered | Raised | Price | 3/9/18 | Change |
| BioXcel Therapeutics (BTAI) | Barclays/ UBS Investment Bank/ BMO Capital Markets | 5.45 | $60.00 | $11.00 | $11.00 | 0.00% |
